Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M603345200 on July 14, 2006

J. Biol. Chem., Vol. 281, Issue 38, 27765-27772, September 22, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
281/38/27765    most recent
M603345200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lebrun, A.-H.
Right arrow Articles by Warnecke, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lebrun, A.-H.
Right arrow Articles by Warnecke, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cloning of a Cholesterol-{alpha}-glucosyltransferase from Helicobacter pylori*Formula

Anne-Helene Lebrun{ddagger}1, Christian Wunder§12, Janosch Hildebrand{ddagger}1, Yuri Churin§, Ulrich Zähringer, Buko Lindner, Thomas F. Meyer§, Ernst Heinz{ddagger}, and Dirk Warnecke{ddagger}3

From the {ddagger}Biocenter Klein Flottbek and Botanical Garden, University of Hamburg, Ohnhorststrasse 18, 22609 Hamburg, Germany, the §Department of Molecular Biology, Max Planck Institute for Infection Biology, Schumannstrasse 21-22, 10117 Berlin, Germany, and the Research Center Borstel, Leibniz-Center for Medicine and Biosciences, 23845 Borstel, Germany

O-Glycans of the human gastric mucosa show antimicrobial activity against the pathogenic bacterium Helicobacter pylori by inhibiting the bacterial cholesterol-{alpha}-glucosyltransferase (Kawakubo, M., Ito, Y., Okimura, Y., Kobayashi, M., Sakura, K., Kasama, S., Fukuda, M. N., Fukuda, M., Katsuyama, T., and Nakayama, J. (2004) Science 305, 1003–1006). This enzyme catalyzes the first step in the biosynthesis of four unusual glycolipids: cholesteryl-{alpha}-glucoside, cholesteryl-6'-O-acyl-{alpha}-glucoside, cholesteryl-6'-O-phosphatidyl-{alpha}-glucoside, and cholesteryl-6'-O-lysophosphatidyl-{alpha}-glucoside. Here we report the identification, cloning, and functional characterization of the cholesterol-{alpha}-glucosyltransferase from H. pylori. The hypothetical protein HP0421 from H. pylori belongs to the glycosyltransferase family 4 and shows similarities to some bacterial diacylglycerol-{alpha}-glucosyltransferases. Deletion of the HP0421 gene in H. pylori resulted in the loss of cholesteryl-{alpha}-glucoside and all of its three derivatives. Heterologous expression of HP0421 in the yeast Pichia pastoris led to the biosynthesis of ergosteryl-{alpha}-glucoside as demonstrated by purification of the lipid and subsequent structural analysis by nuclear magnetic resonance spectroscopy and mass spectrometry. In vitro enzyme assays were performed with cell-free homogenates obtained from cells of H. pylori or from transgenic Escherichia coli, which express HP0421. These assays revealed that the enzyme represents a membrane-bound, UDP-glucose-dependent cholesterol-{alpha}-glucosyltransferase.


Received for publication, April 7, 2006 , and in revised form, June 29, 2006.

* This work was supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 470. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

1 These authors contribute equally to this work.

2 Present address: Cell Biology and Metabolism Branch, National Institutes of Health, 18 Library Dr., Bethesda, MD 20892.

3 To whom correspondence should be addressed: Biocenter Klein Flottbek and Botanical Garden, University of Hamburg, Ohnhorststr. 18, 22609 Hamburg, Germany. Tel.: 49-40-42816-343; Fax: 49-40-42816-254; E-mail: warnecke{at}botanik.uni-hamburg.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
H. Lee, P. Wang, H. Hoshino, Y. Ito, M. Kobayashi, J. Nakayama, P. H Seeberger, and M. Fukuda
{alpha}1,4GlcNAc-capped mucin-type O-glycan inhibits cholesterol {alpha}-glucosyltransferase from Helicobacter pylori and suppresses H. pylori growth
Glycobiology, July 1, 2008; 18(7): 549 - 558.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement